Dataset Open Access
Harding, Rachel;
Lemak, Sasha;
Arrowsmith, Cheryl
@dataset{harding_rachel_2018_2207216, author = {Harding, Rachel and Lemak, Sasha and Arrowsmith, Cheryl}, title = {{SAXS data collection and analysis of Q23 HTT and HTT-HAP40 samples - 2018/10/08}}, month = oct, year = 2018, note = {{Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research. Dr. Harding's research is also supported with generous funding from the Huntington Society of Canada and the CHDI Foundation. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.}}, publisher = {Zenodo}, doi = {10.5281/zenodo.2207216}, url = {https://doi.org/10.5281/zenodo.2207216} }
All versions | This version | |
---|---|---|
Views | 101 | 102 |
Downloads | 13 | 13 |
Data volume | 74.7 MB | 74.7 MB |
Unique views | 83 | 84 |
Unique downloads | 10 | 10 |